Ki16425

Catalog No. A10501

ki16425是对LPA1和LPA3具有选择性的LPA受体拮抗剂,对人LPA1、LPA2和LPA3受体分别显示Ki值为0.34、6.5和0.93 μM。
  • Maria F Fernandes, .et al. Glucagon-like Peptide-1 Secretion Is Inhibited by Lysophosphatidic Acid, Int J Mol Sci, 2022, Apr 9;23(8):4163 PMID: 35456981
  • Rieko Suenaga, .et al. Lateral access mechanism of LPA receptor probed by molecular dynamics simulation, PLoS One, 2022, Feb 3;17(2):e0263296 PMID: 35113924
  • Inoue A, .et al. Illuminating G-Protein-Coupling Selectivity of GPCRs, Cell, 2019, Jun 13;177(7):1933-1947 PMID: 31160049
  • Taniguchi R, .et al. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6, Nature, 2017, Aug 17;548(7667):356-360 PMID: 28792932
  • T. HASHIMOTO, .et al. Generalized pruritus in primary sclerosing cholangitis: implications of histamine release by lysophosphatidic acid., Br J Dermatol., 2015, Nov;173(5):1334-6 PMID: 26122943
Catalog Num A10501
M. Wt 475.0
Formula C23H23ClN2O5S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 355025-24-0
Synonyms Ki 16425, Ki-16425
SMILES CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)CSCCC(=O)O
ki16425是对LPA1和LPA3具有选择性的LPA受体拮抗剂,对人LPA1、LPA2和LPA3受体分别显示Ki值为0.34、6.5和0.93 μM。
In vitro (25°C) DMSO 85 mg/mL (178.96 mM)
Water Insoluble
Ethanol 85 mg/mL (178.96 mM)
In vivo 5% DMSO+95% Corn oil 28 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 21.05 mL 105.26 mL 210.53 mL
0.5 mM 4.21 mL 21.05 mL 42.11 mL
1 mM 2.11 mL 10.53 mL 21.05 mL
5 mM 0.42 mL 2.11 mL 4.21 mL

*The above data is based on the productmolecular weight 475.0 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.